Fundz

Gel Sana Therapeutics reported raising $3.48 Million in an initial SEC Form D filing, from an offering of $3.18 Million

PRIVATEDec 04, 2023

Amount Raised

$3.48 Million

$3.48 Million sold, per SEC Form D (first sale Nov 20, 2023)

Round Type

Seed

GoldenSoftwareData And AnalyticsHealth Care

Quick answer

GelSana Therapeutics raised $3.48 Million in a Seed round, dated November 20, 2023. GelSana Therapeutics is based in Golden, Colorado, United States.

How much did GelSana Therapeutics raise?
GelSana Therapeutics raised $3.48 Million in a Seed round on November 20, 2023.
What does GelSana Therapeutics do?
GelSana Therapeutics is a Colorado-based biomaterials company intentionally designing new materials to improve wound healing.
Where is GelSana Therapeutics based and how big is it?
GelSana Therapeutics is based in Golden, Colorado, United States. Fundz records about 9 employees.
Who are the decision-makers at GelSana Therapeutics?
Fundz holds 1 contact at GelSana Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Data And Analytics and Software around the same time

Companies in the same sectors as GelSana Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Kythera Labs raised $20M (Funding Round) on November 7, 2023.
  • Zephyr AI, Inc. raised $111M on October 27, 2023.
  • Luna Innovations Incorporated raised $50M on December 21, 2023.
  • Luna Innovations Incorporated raised $50M (Corporate Round) on December 21, 2023.
  • Atavistik Bio raised $40M (Funding Round) on December 19, 2023.
  • Laza Medical raised $36M (Series A) on December 12, 2023.

Who to call at GelSana Therapeutics, and when

A new round usually means GelSana Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day GelSana Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at GelSana Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at GelSana Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

GelSana Therapeutics

Location

12635 E MONTVIEW BLVD STE 216

Golden, Colorado, United States

About

GelSana Therapeutics is a Colorado-based biomaterials company intentionally designing new materials to improve wound healing. Our materials are anti-inflammatory, prevent bacterial adhesion, and are capable of controlled drug delivery.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment GelSana Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for GelSana Therapeutics's next move

See what Strategic adds

GelSana Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.